RCPT

Receptos to Hold First Quarter 2014 Financial Results Conference Call and Webcast

[GlobeNewswire] – SAN DIEGO — Receptos, Inc. , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, will announce financial results for the first quarter ended … moreView todays social media effects on RCPTView the latest stocks trending across Twitter. Click to view dashboardSee who Receptos is hiring next, click here to view […]

Receptos to Present at Bank of America Merrill Lynch 2014 Health Care Conference

[GlobeNewswire] – SAN DIEGO — Receptos, Inc. , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced that management will be presenting at the … moreView todays social media effects on RCPTView the latest stocks trending across Twitter. Click to view dashboardSee who Receptos is hiring next, click here to view […]

Receptos to Hold Fourth Quarter and Year End 2013 Financial Results Conference Call and Webcast

[GlobeNewswire] – SAN DIEGO — Receptos, Inc. , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, will announce financial results for the fourth quarter and … moreView todays social media effects on RCPTView the latest stocks trending across Twitter. Click to view dashboardSee who Receptos is hiring next, click here to view […]

Sheila Gujrathi, M.D., Joins Ambrx Board of Directors

[PR Newswire] – SAN DIEGO, Feb. 24, 2014 /PRNewswire/ — Ambrx Inc. today announced that Sheila Gujrathi, M.D., has joined its board of directors. Dr. Gujrathi is currently the chief medical officer at Receptos (RCPT) where she is responsible for the cli moreView todays social media effects on RCPTView the latest stocks trending across Twitter. Click to view dashboardSee who […]